Evaluating tools to communicate scleroderma research results to patients - SPIN-CLEAR Trial Series PPI Sub-study #3

A randomized controlled trial to compare the effectiveness of dissemination tools to share research results with patients - A SPIN-CLEAR Trial Series Patient and Public Involvement Sub-study #3

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN82301860

Enrollment

128

Registered

2026-02-25

Start date

2026-10-23

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of research dissemination tools to people living with systemic sclerosis (SSc

Interventions

The investigators will use the multinational SPIN Cohort to conduct a series of RCTs to compare tools among people with systemic sclerosis, or scleroderma. This trial in the sub-study series of trials

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eligible participants will include SPIN Cohort participants and others with systemic sclerosis (SSc; also known as scleroderma) who participated in previous SPIN-CLEAR trials or a SPIN online patient-oriented research event. 1. Enrollment in SPIN Cohort, which requires a systemic sclerosis (SSc) classification by a site physician based on 2013 American College of Rheumatology/European League Against Rheumatism criteria, =18 years old, being fluent in English or French, and have completed one SPIN Cohort assessment in the last year. 2. External enrollment with patient-reported physician classification of SSc and aged 18 years or older.

Exclusion criteria

Exclusion criteria: Patients not able to access or respond to questionnaires via the internet.

Countries

Canada

Contacts

Public ContactBrett Thombs

brett.thombs@mcgill.ca+1 (0)514 340 8222

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026